Neurology
RSSArticles
-
Pharmacology Watch
Rivaroxaban may be dabigatran's first competitor; a new way to measure non-adherence to medication therapy; FDA Actions. -
Clinical Briefs in Primary Care Supplement
-
Lacosamide as Adjunctive Therapy in Nonconvulsive Status Epilepticus
The authors report a small, retrospective case series using low-dose intravenous lacosamide in the successful, adjunctive treatment of nonconvulsive status epilepticus. -
Pharmacology Watch - Full January 2011 Issue in PDF
-
Another Warfarin Replacement on Horizon
-
FDA Actions
-
Non-adherence: A New Way to Measure
-
Hospital Medicine Alert - Full January 2011 Issue in PDF
-
QI Process Promotes Early Mobilization of ICU Patients
Using a quality improvement (QI) process, ICU delirium, physical rehabilitation, and functional mobility were significantly improved and associated with a decreased length of stay. -
Intravenous Peramivir for Seasonal Influenza
Outpatients with uncomplicated seasonal influenza were treated with single doses of IV peramivir 300 mg/kg, 600 mg/kg, or placebo. Peramivir significantly reduced the time to alleviation of symptoms at both doses compared with placebo. Peramivir was well-tolerated, and side effects were comparable to placebo.